Development and Validation of a Method for the Quantitative Determination of Etoricoxib in Liquid Dosage Form

Introduction. Etoricoxib is a selective cyclooxygenase (COX-2) inhibitor used for the treatment of acute pain and has anti-inflammatory and analgesic efficacy. Etoricoxib causes fewer complications compared to other non-steroidal anti-inflammatory drugs (NSAIDs). FSI "SID and GP" has devel...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Kh. Amandusova, A. E. Kovalenko, A. V. Morozov, K. R. Savelyeva, T. L. Batalova, O. A. Ostapyuk, L. V. Persanova, T. Yu. Andreevicheva, A. G. Beniashvili, V. N. Shestakov, S. V. Polyakov
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-05-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	etoricoxib liquid dosage form high performance liquid chromatography (hplc) validation
Online Access:	https://www.pharmjournal.ru/jour/article/view/1488
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Development and Validation of a Method for the Quantitative Determination of Etoricoxib in Liquid Dosage Form

Similar Items